|
|
- 2018
结合2015版ATA指南对甲状腺微小乳头状癌热点问题的探讨
|
Abstract:
摘要：近年来，甲状腺癌的发病率越来越高，其中甲状腺微小乳头状癌(papillary thyroid microcarcinoma, PTMC)占了很大的比例。由于PTMC的预后较好，不断有新的研究发表，并提出新的诊治观点，因此关于PTMC的诊断和治疗已成为甲状腺外科的最热门话题之一。本文结合美国甲状腺学会2015年发布的甲状腺结节与分化型甲状腺癌的诊治指南，围绕PTMC的热点问题做一探讨。
ABSTRACT: In recent years, the incidence of thyroid cancer has been increasing, and papillary thyroid microcarcinoma (PTMC) has become a major component in newly diagnosed thyroid cancers. Since the prognosis of PTMC is favorable, new viewpoints in diagnosis and treatment of PTMC have been constantly put forward by new research. Therefore, diagnosis and treatment of PTMC has become one of the most popular topics in thyroid surgery. In this article, we discuss the hot issues in PTMC based on the 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer
| [1] | HOTOMI M, SUGITANI I, TODA K, et al. A novel definition of extrathyroidal invasion for patients with papillary thyroid carcinoma for predicting prognosis[J]. World J Surg, 2012, 36(6):1231-1240. |
| [2] | SUGITANI I, FUJIMOTO Y, YAMADA K. Association between serum thyrotropin concentration and growth of asymptomatic papillary thyroid microcarcinoma[J]. World J Surg, 2014, 38(3):673-678. |
| [3] | PELLEGRITI G, FRASCA F, REGALBUTO C, et al. Worldwide increasing incidence of thyroid cancer: Update on epidemiology and risk factors[J]. J Cancer Epidemiol, 2013, 2013(1):965212. |
| [4] | DAVIES L, WELCH HG. Current thyroid cancer trends in the United States[J]. JAMA Otolaryngol Head Neck Surg, 2014, 140(4):317-322. |
| [5] | 孙嘉伟，许晓君，蔡秋茂，等. 中国甲状腺癌发病趋势分析[J]. 中国肿瘤, 2013. 22(9):690-693. |
| [6] | QU N, ZHANG L, JI QH, et al. Risk factors for central compartment lymph node metastasis in papillary thyroid microcarcinoma: A meta-analysis[J]. World J Surg, 2015, 39(10):2459-2470. |
| [7] | MEHANNA H, ALMAQBILI T, CARTER B, et al. Differences in the recurrence and mortality outcomes rates of incidental and nonincidental papillary thyroid microcarcinoma: A systematic review and meta-analysis of 21 329 person-years of follow-up[J]. J Clic Endocr Metab, 2014, 99(8):2834-2843. |
| [8] | SOLORZANO CC, CARNEIRO DM, RAMIREZ M, et al. Surgeon-performed ultrasound in the management of thyroid malignancy[J]. Am Surgeon, 2004, 70(7):576-580. |
| [9] | ITO Y, ODA H, MIYAUCHI A. Insights and clinical questions about the active surveillance of low-risk papillary thyroid microcarcinomas [Review][J]. Endocr J, 2015, 63(4):323-328. |
| [10] | HAY ID, HUTCHINSON ME, GONZALEZ-LOSADA T, et al. Papillary thyroid microcarcinoma: A study of 900 cases observed in a 60-year period[J]. Surgery, 2008, 144(6):980-988. |
| [11] | MD HB, ALEXANDER EK, BIBLE KC, et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer[J]. Thyroid, 2016, 26(1):1-133. |
| [12] | COOPER DS, DOHERTY GM, HAUGEN BR, et al. Revised American thyroid association management guidelines for patients with thyroid nodules and differentiated thyroid cancer[J]. Thyroid, 2009, 19(11):1167-1214. |
| [13] | ITO Y, MIYAUCHI A, KIHARA M, et al. Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation[J]. Thyroid, 2014, 24(1):27-34. |
| [14] | LIU X, BISHOP J, SHAN Y, et al. Highly prevalent TERT promoter mutations in aggressive thyroid cancers[J]. Endocr-Relat Cancer, 2013, 20(4):603-610. |
| [15] | XING M, LIU R, LIU X, et al. BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence[J]. J Clin Oncol, 2014, 32(25):2718-2726. |
| [16] | LI F, CHEN G, SHENG C, et al. BRAFV600E mutation in papillary thyroid microcarcinoma: A meta-analysis[J]. Endocr-Relat Cancer, 2015, 22(2):159-168. |
| [17] | YIN DT, YU K, LU RQ, et al. Clinicopathological significance of TERT promoter mutation in papillary thyroid carcinomas: A systematic review and meta-analysis[J]. Clin Endocrinol, 2016, 85(2):299-305. |
| [18] | 殷德涛，张亚原，韩？r，等. 1～4cm分化良好的甲状腺癌选择单侧甲状腺腺叶切除术的效益和风险分析[J]. 国际外科学杂志, 2017, 44(2):115-117. |
| [19] | 中国抗癌协会甲状腺癌专业委员会. 甲状腺微小乳头状癌诊断与治疗中国专家共识(2016版)[J]. 中国肿瘤临床, 2016, 43(10):405-411. |
| [20] | KIM HJ, KIM NK, CHOI JH, et al. Radioactive iodine ablation does not prevent recurrences in patients with papillary thyroid microcarcinoma[J]. Clin Endocrinol, 2013, 78(4):614-620. |
| [21] | CHOW SM, YAU S, KWAN CK, et al. Local and regional control in patients with papillary thyroid carcinoma: Specific indications of external radiotherapy and radioactive iodine according to T and N categories in AJCC 6th edition[J]. Endocr-Relat Cancer, 2007, 13(4):1159-1172. |
| [22] | ITO Y, MIYAUCHI A, INOUE H, et al. An observational trial for papillary thyroid microcarcinoma in Japanese patients[J]. World J Surg, 2010, 34(1):28-35. |
| [23] | DAVIES L, WELCH HG. Increasing incidence of thyroid cancer in the United States, 1973-2002[J]. JAMA-J Am Med Assoc, 2006, 295(18):2164-2167. |
| [24] | HAUCH A, AL-QURAYSHI Z, RANDOLPH G, et al. Total thyroidectomy is associated with increased risk of complications for low- and high-volume surgeons[J]. Ann Surg Oncol, 2014, 21(12):3844-3852. |
| [25] | ITO Y, URUNO TK, TAKAMURA Y, et al. An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid[J]. Thyroid, 2003, 13(4):381-387. |
| [26] | BRITO JP, ITO Y, MIYAUCHI A, et al. A Clinical framework to facilitate risk stratification when considering an active surveillance alternative to immediate biopsy and surgery in papillary microcarcinoma[J]. Thyroid, 2015, 26(1):144-149 |
| [27] | LIM CY, YUN JS, LEE J, et al. Percutaneous ethanol injection therapy for locally recurrent papillary thyroid carcinoma[J]. Thyroid, 2007, 17(4):347-350. |
| [28] | BAEK JH, KIM YS, SUNG JY, et al. Locoregional control of metastatic well-differentiated thyroid cancer by ultrasound-guided radiofrequency ablation[J]. Am J Roentgenol, 2012, 197(2):331-336. |
| [29] | LEBOULLEUX S, TUTTLE RM, PACINI F, et al. Papillary thyroid microcarcinoma: Time to shift from surgery to active surveillance?[J]. Lancet Diabetes Endo, 2016, 4(11):933-942. |
| [30] | ITO Y, MIYAUCHI A. Nonoperative management of low-risk differentiated thyroid carcinoma[J]. Curr Opin Oncol, 2015, 27(1):15-20. |
| [31] | ITO Y, MIYAUCHI A. A therapeutic strategy for incidentally detected papillary microcarcinoma of the thyroid[J]. Nat Clic Pract Endoc, 2007, 3(3):240-248. |
| [32] | 中华医学会内分泌学分会，中华医学会外科学分会内分泌学组，中国抗癌协会头颈肿瘤专业委员会，等. 甲状腺结节和分化型甲状腺癌诊治指南[J]. 中华内分泌代谢杂志, 2012, 28(10):779-797. |
